ABSTRACT. Intracellular levels of cysteine (CSH) and reduced glutathione (GSH) in the kidney and liver of rats from the newborn to the adult period have been determined using a sensitive high performance liquid chromatography method. In the kidney, the intracellular level of free CSH increased 4-fold from 1 to 4 nmol/mg protein with GSH levels which ranged from 20 to 25 nmol/mg protein from the 10th to 21st postnatal day, respectively. In contrast, intracellular free hepatic CSH showed a biphasic pattern with development. Intracellular free hepatic GSH, on the other hand, increased 2-fold over the 3-to 21-day postnatal period. In adult tissues, intracellular levels of free CSH and GSH decreased as compared with levels in 21-day postnatal animals. When ratios of CSH to GSH were compared between tissues from the 3-day-old postnatal and adult rat, CSH:GSH increased approximately 4-fold in the kidney and decreased 2-to 3-fold in the liver. CSH and GSH in isolated renal cortical tubule fragments from dog (4) and rat (5) kidneys, and rat kidney cortical slices (6). In these in vitro systems 80 to 90% of the label was incorporated into intracellular free CSH with approximately 5% appearing in GSH in both neonatal and adult tissues. Several reports have appeared recently on the effect of metabolic perturbation in the intact rat on intracellular levels of GSH (1, 7). The rapid oxidation of GSH to GSSG and the breakdown of the tripeptide to its constituent amino acids, cysteine, glycine, and glutamate. and to the dipeptides, cysteinylglycine, and glutamylcysteine. have resulted in reports of intracellular in vivo levels ranging from 15 to 40 nmol GSH/mg intracellular protein. Only recently has quantitation of free CSH per se been possible and only a single report has appeared from this laboratory on the comparative levels of intracellular GSH in renal cortical slices from newborn and adult rats (8). Utilizing a sensitive HPLC method of separation, we have assayed the in vivo levels of free intracellular CSH and GSH in the liver and kidney of the developing rat. Our results comprise the basis of this report.
CSH and GSH in isolated renal cortical tubule fragments from dog (4) and rat (5) kidneys, and rat kidney cortical slices (6) . In these in vitro systems 80 to 90% of the label was incorporated into intracellular free CSH with approximately 5% appearing in GSH in both neonatal and adult tissues. Several reports have appeared recently on the effect of metabolic perturbation in the intact rat on intracellular levels of GSH (1, 7). The rapid oxidation of GSH to GSSG and the breakdown of the tripeptide to its constituent amino acids, cysteine, glycine, and glutamate. and to the dipeptides, cysteinylglycine, and glutamylcysteine. have resulted in reports of intracellular in vivo levels ranging from 15 to 40 nmol GSH/mg intracellular protein. Only recently has quantitation of free CSH per se been possible and only a single report has appeared from this laboratory on the comparative levels of intracellular GSH in renal cortical slices from newborn and adult rats (8) . Utilizing a sensitive HPLC method of separation, we have assayed the in vivo levels of free intracellular CSH and GSH in the liver and kidney of the developing rat. Our results comprise the basis of this report.
MATERIALS A N D METHODS
Reagents. CSH . HCI, GSH, DTNB, GSSG, EDTA, and DTT were purchased from Sigma Chemical Co., St. Louis, MO. American Burdick &Jackson HPLC grade methanol was from American Scientific Products, Edison, NJ. All other reagents were either HPLC grade or AR grade and were obtained through Fisher Scientific, King of Prussia, PA.
Animals. Sprague-Dawley 18-day-pregnant female rats were obtained from Charles River Breeding Laboratories, Wilmington, MA. Each rat was housed separately and upon parturition each litter was limited initially to 10 pups with two pups from each mother being killed by decapitation at the appropriate age for assay of CSH and GSH. The pups remaining were weaned at Glutathione is a major cellular reductant with significant roles 18 days of age. No attempt was made to regiment the feeding of in catalysis, metabolism, transport, and detoxification of endog-the newborns. The mothers were supplied with water and were enous and exogenous foreign compounds. Both the rate of syn-fed laboratory rat food ad libitum.
thesis and cellular levels of this tripeptide within the cytoplasm Method of anal-vsis. The HPLC method, a modification of one of mammalian cells depend upon the availability of its precursor, described by Komuro et al. (9) , was performed at room tempercyst(e)ine (I). Cyst(e)ine per se is essential for growth and devel-ature with a Waters model 6000A solvent delivery system opment through its involvement in metabolic processes of pro-equipped with a 10 micron pBondapak C l 8 3.9 mm x 30 cm tein synthesis and its sparing effect on transsulfuration and column to which were attached a Waters model U6K injector transmethylation (2, 3) . Both thiol compounds, therefore, play and a model 440 absorbance detector with dual channel amplifier major roles in maintaining the homeostasis of the metabolizing module, 365 and 254 wavelength analytical cells and photocell.
detector assemblies. The eluate concentrations were recorded on The few data in the literature on cyst(e)ine metabolism with an OmniScribe B-5000 strip chart recorder preset to 100% scale development have dealt mainly with determination of the uptake deflection at 0.005 absorbance units for 365 nm and 100% at of labeled cystine and its intracellular conversion to free labeled 0.20 absorbance units for 254 nm. HCI was prepared in 10 ml 0.01 M EDTA-5% TCA. This solution was mixed well and a CSH standard prepared with 0.25 ml of the above CSH stock solution added to 2.50 ml 0.02 M EDTA, 1.75 ml H20, and 0.50 ml 50% TCA. Just prior to injection, 1 ml standard CSH was added to 4 ml Tris . HCI buffer pH 8.9. After addition of 0.1 ml 10 mM DTNB (prepared in methanol), the mixture was filtered through a 0.22-~rn filter and injected. The lower limit of sensitivity for CSH was 5 pmol. The GSH stock was prepared as a 1 mM solution in 10 ml 0.01 M EDTA-5% TCA. Prior to injection, 0.2 ml of the stock GSH was added to 1.8 ml EDTA-TCA, 4.0 m10.4 M Tris. HCI buffer pH 8.9 and 0.1 ml 10 mM DTNB. This GSH standard was filtered also through a 0.22-pM filter. The lower limit of sensitivity for GSH was 15 pmol. To determine CSSC and oxidized glutathione, stock solutions of the disulfides were prepared in the same manner as their thiol counterparts and were reduced with DTT to CSH and GSH, respectively, as follows: a 0.5-ml aliquot of standard CSSC was added to 4.0 ml Tris. HCI buffer pH 8.9, 0. I ml DTT (6.6 mg/lO ml), and sufficient Hz0 was added for a total volume of 6 ml. With GSSG, a 0.1-ml aliquot of the disulfide was added to 4.0 ml TrisHCl buffer pH 8.9, 0.3 ml DTT, and sufficient HzO for a total volume of 5.8 ml. After 1 h with periodic mixing, 0.1 and 0.3 ml of DTNB were added to the reduced CSSC and glutathione standards, respectively. The mixture was filtered and an aliquot injected. Recovery of CSH and GSH added to tissue extracts was essentially 100% as reported by Komuro et al. (9) . Recovery of CSSC as CSH and GSSG as GSH was 100%. The retention times were reproducible with CSH at 7.5 min, glutamylcysteine at 9.5 min, and GSH at 18 min (Fig. 1) . The peak with a retention time of 11 to 12 min corresponded to the 2-nitro-5-thiobenzoic acid referred to by Komuro et al. (9) . Tissue preparation. Animals were killed at approximately the same time of day for each study. Within 1 min after the pups were decapitated, the kidneys were removed, decapsulated, minced into small pieces, and placed in cold 0.01 M EDTA-5% TCA contained in a 15-ml Kontes dounce homogenizer. A portion of the liver also was removed, minced, and placed in cold 0.01 M EDTA-5% TCA. Each tissue was homogenized in the cold 10 times with a A (loose) pestle and 10 times with a B Fig. 1 . HPLC chromatography pattern and elution time for ( 1 ) CSH, 7.5 min; (2) glutamylcysteine, 9.5 min; (3) 2-nitro-5-thiobenzoic acid, 1 1-1 2 min, and (4) GSH, 18 min.
(tight) pestle. The homogenates (5-10% wet weight of tissue/vol) were placed on ice for 15 min and then were centrifuged at 10,000 x g a t 4°C for 10 min. After centrifugation, the supernatant was removed and either stored immediately at -40" C for no longer than 1 wk or prepared for immediate assay of CSH and GSH. Levels of free CSH and GSH in the frozen supernatants did not change significantly after l wk of storage at -40" C. The protein content of the supernatant was determined by the method of Lowry et al. (10) .
Preparation of assay samples. Five min before assay 2 ml of the above supernatants were added to 4 ml 0.4 M Tris.HC1 buffer pH 8.9 followed by 0.1 ml 10 mM Ellman's reagent (DTNB). The mixtures were shaken periodically for 3 min and then filtered through a Millex-GS 0.22-~rn filter unit. A 5-to 20-p1 aliquot was analyzed immediately for CSH and GSH. Figure 2 shows the pattern of intracellular levels of free CSH and GSH in developing kidney and liver. CSSC and GSSG were not present in detectable amounts in either tissue, i.e., less than 0.25 nmol CSSC/mg protein and less than 1.5 nmol GSSG/mg protein. In the kidney, the intracellular level of free CSH stayed constant at about 1 nmol/mg protein for 10 days and then increased significantly ( p < 0.001) to 4 nmol/mg protein by 21 days. The latter level was also found in adult kidney. In contrast, the level of intracellular free GSH showed a biphasic pattern with a significant (p < 0.00 1) increase from 1 1.84 + 1.08 (SEM) to 25.85 + 0.93 nmol/mg protein from term to the 3rd postnatal day, respectively. By the 7th day, intracellular free GSH levels had fallen to 19.78 + 1.07 nmol/mg protein. Free intracellular GSH levels plateaued from the 7th through the 14th day. On day 21 (3 days after the pups were weaned), the intracellular GSH levels had increased to 27.15 k 2.92 nmol/mg protein. In the kidney of the mature animal, the quantity of intracellular free CSH did not differ significantly from that found in the 21 day old; however, intracellular free GSH had returned to a level which did not significantly differ from that found in the kidneys from the 7-to 14-day-old animals. Figure 2 also shows the levels of intracellular free CSH and GSH in developing liver. Intracellular hepatic free CSH was less than 1.0 nmol/mg protein in the neonate and adult rat. In contrast to increasing free kidney CSH, hepatic CSH levels presented a biphasic pattern during liver development (Fig. 2) . In the beginning, free CSH was relatively high [i.e. day 3 at 0. Fig. 2) . From the 3rd to the 7th postnatal day, free hepatic GSH increased significantly to 33.72 + 1.79 nmol/mg protein ( p < 0.001). The upsurge in free GSH over this early neonatal period was followed by a plateauing of intracellular GSH from the 7th to loth postnatal days. From the loth to 2 1st day after term, intracellular free GSH rose significantly from 30.78 & 3.71 to 46.39 + 3.9 1 nmol/mg protein, respectively ( p < 0.00 1). Weaning of pups on the 18th day may have had a pronounced affect on the elevated GSH observed on the 21st postnatal day (I I). Free hepatic GSH then decreased from 46.39 on the 21st day after term to 29.28 -t 1.44 nmol/mg protein in adult liver ( p < 0.0 I ).
RESULTS

Ontogeny of intracellularfree CSH and GSH.
Compuri.von r!f'CSII:Wf in d~vc~loping kidney arrd liver. The synthesis of GSH in vivo is dependent, in part, on the availability of precursor, CSH ( 1, 12, 13). T o obtain a better understanding of the relation between the intracellular free levels of these two thiols during development, the ratios of CSH:GSH were calculated. In the kidney, the ratio of CSH to GSH remained constant at approximately 0.04 from the 3rd to the loth postnatal day. From day 10 to day 2 1, however, the ratio increased 3.6-fold to 0.14, respectively. The CSH:GSH ratios in the 3-day-old neonate were not significantly different in liver and kidney. However, instead of increasing as in the kidney, liver ratios decreased gradually from 0.04 on the 3rd postnatal day to 0.0 1 in the 2 1 day old. In order to show more clearly the differences in CSH:GSH between developing kidney and liver, the ratio of the 3 day old was selected as the common denominator for comparison of changing CSH:GSH with development. These calculations (Fig. 3) show the following: (I) in the kidney (a) the ratio of CSH to GSH remained constant from the 3rd to the loth postnatal day and (b) from the loth to 21st days the ratios increased 3.6 fold; (11) in the liver (a) the ratio decreased more than 50% from the 3rd to 7th day and (b) the ratios continued to decrease gradually from the 10th through 21st postnatal day resulting in a ratio in the 21 day old which approximated 25%
of that calculated for the 3-day-old neonate.
DISCUSSION
Glutathione and CSH are two important intracellular thiols. Glutathione plays a vital role in a number of fundamental cellular processes, not the least of which is protection from oxidative stress. The amino acid, CSH, is an important constituent of most proteins, determining the tertiary structure through disulfide bridges. Further, CSH is one of the three amino acids; CSH, glycine, and glutamate, which make up glutathione. It is the sulthydryl group of CSH which allows glutathione to perform its reducing function.
In the immature animal the activity of the enzyme cystathionase, important in converting the essential amino acid methionine to CSH, is low (14, 15) . This has led some investigators to question whether CSH may be an essential amino acid in the newborn (14) . Because of this question and the importance of these thiols in cellular metabolism, we examined the intracellular content of CSH and GSH in the developing rat.
In the kidney, CSH remained low throughout the nursing period, but rose by 3 wk of age in concert with weaning. GSH rose to adult levels by the 3rd day of life falling somewhat by the end of the 1st postnatal wk. With the onset of weaning, GSH rose again and then returned to a level similar to that of the I wk old.
In the liver, the intracellular CSH was much lower than that found in the kidney throughout development and this difference was most marked after weaning when the CSH content of the kidney went up significantly. Also in contrast to the kidney, the highest CSH levels were noted soon after birth. However, this elevated CSH fell 44% by the 10th day of life. From the 10th to STATES the 14th day of life, the CSH content rose to a level similar to the 3 day old, but then it fell again by 57% with maturity. GSH, on the other hand, rose during the nursing period and peaked with weaning. It then fell with attainment of adulthood to levels comparable to the 2nd wk of life. The intracellular levels of these thiols are dependent on numerous factors, many of which have not been well characterized. Obviously the balance between synthesis and degradation or use is an important determining factor of these levels. The activity of cystathionase, an enzyme in the transsulfuration pathway converting methionine to CSH, is low in the neonate, limiting CSH synthesis, but rises with development (14, 15) . Other influences are dietary intake and movement into and out of the cells in the kidney and liver. CSSC, the circulating form of CSH, is rapidly taken up by immature rat renal tubule cells at a rate comparable to the adult, while movement out of the cell appears to be slower (5) . Whether development of the liver affects CSSC or CSH uptake is not known.
More is known about glutathione synthesis and degradation. Gamma-glutamylcysteine synthetase activity in the kidney appears earlier (16) than the activity of GGTPase (1 7), the degradative enzyme. This is consistent with our findings of a higher GSH level in the kidney at 3 days of life compared to later values, except for just after weaning. In the liver, GGTPase activity is highest at birth and then declines (18) . Further, the activity of this enzyme in liver is quite low compared to kidney leading to the hypothesis that GSH is principally formed in the liver and degraded at extrahepatic sites, such as the kidney (1 8). However, at this time not enough is known about the developmental pattern of the hepatic GSH synthesizing enzymes to interpret the pattern of hepatic GSH levels we have observed. Further research is needed examining the changes in these enzymes, as well as GSH turnover rates, in developing animals to understand fully the influences governing these intracellular levels.
